122 related articles for article (PubMed ID: 9302401)
1. Genomic sequence analysis of a key residue (Arg183) in human G alpha q in invasive non-functional pituitary adenomas.
Farrell WE; Talbot JA; Bicknell EJ; Simpson D; Clayton RN
Clin Endocrinol (Oxf); 1997 Aug; 47(2):241-4. PubMed ID: 9302401
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenomas: screening for G alpha q mutations.
Oyesiku NM; Evans CO; Brown MR; Blevins LS; Tindall GT; Parks JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):4184-8. PubMed ID: 9398737
[TBL] [Abstract][Full Text] [Related]
3. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes.
Dong Q; Brucker-Davis F; Weintraub BD; Smallridge RC; Carr FE; Battey J; Spiegel AM; Shenker A
J Clin Endocrinol Metab; 1996 Mar; 81(3):1134-40. PubMed ID: 8772588
[TBL] [Abstract][Full Text] [Related]
4. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours.
Williamson EA; Daniels M; Foster S; Kelly WF; Kendall-Taylor P; Harris PE
Clin Endocrinol (Oxf); 1994 Dec; 41(6):815-20. PubMed ID: 7889619
[TBL] [Abstract][Full Text] [Related]
5. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas.
Boothroyd CV; Grimmond SM; Cameron DP; Hayward NK
Biochem Biophys Res Commun; 1995 Jun; 211(3):1063-70. PubMed ID: 7598693
[TBL] [Abstract][Full Text] [Related]
6. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
Faccenda E; Melmed S; Bevan JS; Eidne KA
Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
[TBL] [Abstract][Full Text] [Related]
7. G protein abnormalities in pituitary adenomas.
Spada A; Lania A; Ballarè E
Mol Cell Endocrinol; 1998 Jul; 142(1-2):1-14. PubMed ID: 9783897
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a protein kinase C-alpha mutation in human pituitary tumours.
Schiemann U; Assert R; Moskopp D; Gellner R; Hengst K; Gullotta F; Domschke W; Pfeiffer A
J Endocrinol; 1997 Apr; 153(1):131-7. PubMed ID: 9135578
[TBL] [Abstract][Full Text] [Related]
10. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
Landis CA; Masters SB; Spada A; Pace AM; Bourne HR; Vallar L
Nature; 1989 Aug; 340(6236):692-6. PubMed ID: 2549426
[TBL] [Abstract][Full Text] [Related]
11. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.
Williamson EA; Ince PG; Harrison D; Kendall-Taylor P; Harris PE
Eur J Clin Invest; 1995 Feb; 25(2):128-31. PubMed ID: 7737262
[TBL] [Abstract][Full Text] [Related]
12. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; van Leeuwen IS; Sprang EP; Mol JA
J Endocrinol Invest; 1997 Jan; 20(1):1-7. PubMed ID: 9075064
[TBL] [Abstract][Full Text] [Related]
13. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours.
Clementi E; Malgaretti N; Meldolesi J; Taramelli R
Oncogene; 1990 Jul; 5(7):1059-61. PubMed ID: 2115641
[TBL] [Abstract][Full Text] [Related]
14. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C activation in rat pituitary adenoma (GH) cells.
Gordeladze JO; Haugen T; Paulssen EJ; Paulssen RH
Biosci Rep; 1996 Feb; 16(1):65-74. PubMed ID: 8861541
[TBL] [Abstract][Full Text] [Related]
16. GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.
Vallar L
Biochem Soc Symp; 1990; 56():165-70. PubMed ID: 2124121
[TBL] [Abstract][Full Text] [Related]
17. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.
Drews RT; Gravel RA; Collu R
Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784
[TBL] [Abstract][Full Text] [Related]
18. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Itakura M
Cancer; 1993 Aug; 72(4):1386-93. PubMed ID: 8339229
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of protein kinase A catalytic subunit in thyroid adenomas and pituitary tumours.
Esapa CT; Harris PE
Eur J Endocrinol; 1999 Oct; 141(4):409-12. PubMed ID: 10526256
[TBL] [Abstract][Full Text] [Related]
20. The GnRH receptor gene is preferentially expressed in functioning gonadotroph adenomas and displays a Mae III polymorphism site.
Kottler ML; Seret-Bégué D; Lahlou N; Assayag M; Carré MC; Lagarde JP; Ajzenberg C; Christin-Maitre S; Bouchard P; Mikol J; Counis R; Warnet A
Clin Endocrinol (Oxf); 1998 Jul; 49(1):115-23. PubMed ID: 9797855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
